Diabetes Management in Chronic Kidney Disease Source: Kidney Disease: Improving Global Outcomes +++

https://reference.medscape.com/cc2/p10/clinical-practice-guideline-diabetes-management-chronic-2022a1001a4d?ecd=WNL_drugguide_260204_MSCPREF_endo_etid8076742&uac=148436CN&impID=8076742 Latest Guidance Updates November 2022: updates to the sections on top takeaways for clinicians, comprehensive care, glycaemic monitoring and targets, lifestyle interventions, and glucose-lowering therapies. This update includes five updated algorithms, and new sections on sodium–glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists. Standards of Care in Diabetes: Part 1 Source: American Diabetes Association; Medically Reviewed by Dr Roger Henderson https://reference.medscape.com/cc2/p10/guideline-essentials-2025-american-diabetes-association-2025a100074f?ecd=WNL_drugguide_260204_MSCPREF_endo_etid8076742&uac=148436CN&impID=8076742 The American Diabetes Association (ADA) has updated its guidance on standards of care in diabetes for 2025.[1] This guideline overview for GPs, the first in a series on this comprehensive guideline, focuses on the clinical presentation, classification, identification, and diagnosis of diabetes with reference to other key guidance on diabetes management. The recommendations cover the management of type 1 diabetes, type 2 diabetes, gestational diabetes, and other forms of diabetes or hyperglycaemia in all age groups. Hyperglycaemia Management in Type 2 Diabetes Source: American Diabetes Association, European Association for the Study of Diabetes; Medically Reviewed by Dr Kevin Fernando https://reference.medscape.com/cc2/p10/guideline-essentials-key-takeaways-ada-easd-2022-consensus-2023a1000h4j?ecd=WNL_drugguide_260204_MSCPREF_endo_etid8076742&uac=148436CN&impID=8076742 Type 2 diabetes is a complex condition that affects millions of people worldwide. Diabetes UK estimates that more than 5 million people live with diabetes in the UK.[1] Of those, around 90% live with type 2 diabetes.[1] Management of type 2 diabetes must encompass not only blood glucose level control, but also consider weight and cardiovascular (CV) risk, as well as any interactions between the condition and its treatments with other comorbidities.